Cleared Traditional

K190527 - GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term Hemodialysis Catheters, HemoStar XK Long-Term Hemodialysis Catheters (FDA 510(k) Clearance)

Mar 2020
Decision
367d
Days
Class 2
Risk

K190527 is an FDA 510(k) clearance for the GlidePath Long-Term Hemodialysis Catheters, HemoStar Long-Term Hemodialysis Catheters, HemoStar XK Long-Term Hemodialysis Catheters. This device is classified as a Catheter, Hemodialysis, Implanted (Class II - Special Controls, product code MSD).

Submitted by C. R. Bard (Salt Lake Ciy,, US). The FDA issued a Cleared decision on March 5, 2020, 367 days after receiving the submission on March 4, 2019.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5540.

Submission Details

510(k) Number K190527 FDA.gov
FDA Decision Cleared Substantially Equivalent - Special 510(k) (SESK)
Date Received March 04, 2019
Decision Date March 05, 2020
Days to Decision 367 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code MSD - Catheter, Hemodialysis, Implanted
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5540